IDiyas

For the Inventor, By the Inventor

Valby, Denmark

Tobias Gylling Frihed

USPTO Granted Patents = 7 

Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 52(Granted Patents)


Company Filing History:

goldMedal7 out of 506 
 
H. Lundbeck A/s
 patents

Years Active: 2021-2025

Loading Chart...
7 patents (USPTO):Explore Patents
1. 12479801 - Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4',5′:5,6]benzo[1,2-g]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoline-6,7-diol (2025-11-25),
2. 12398169 - Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid (2025-08-26),
3. 11858954 - Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid (2024-01-02),
4. 11851456 - Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid (2023-12-26),
5. 11168056 - Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4',5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol (2021-11-09),
6. 11130775 - Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid (2021-09-28),
7. 11111263 - Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid (2021-09-07),

Title: Innovations by Tobias Gylling Frihed

Introduction

Tobias Gylling Frihed is a notable inventor based in Valby, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. With a total of 7 patents to his name, his work is recognized for its potential impact on medical science.

Latest Patents

Among his latest patents is a process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid. This invention relates to a method for producing a prodrug of a catecholamine, which is intended for use in treating neurodegenerative diseases such as Parkinson's Disease. Additionally, he has developed new solid forms of the same compound, further enhancing its therapeutic potential.

Career Highlights

Tobias is currently employed at H. Lundbeck A/S, a company renowned for its focus on brain diseases. His work at Lundbeck has allowed him to explore innovative solutions in the pharmaceutical industry, contributing to advancements in treatment options for patients.

Collaborations

He collaborates with esteemed colleagues, including Martin Juhl and Frans Dennis Therkelsen, who share his commitment to advancing medical science through innovative research.

Conclusion

Tobias Gylling Frihed's contributions to the field of pharmaceuticals highlight his dedication to improving treatments for neurodegenerative diseases. His innovative patents and collaborative efforts position him as a significant figure in the medical research community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…